Calendar Viridian Therapeutics, Inc.

Equities

VRDN

US92790C1045

Market Closed - Nasdaq 04:00:00 2024-05-24 pm EDT 5-day change 1st Jan Change
12.11 USD -0.41% Intraday chart for Viridian Therapeutics, Inc. -9.96% -44.40%

Chart calendar Viridian Therapeutics, Inc.

f.QK-6yEEdmAtxWVMXazgafy661PzxrunJcS-ZbMbquNA.duqJhyZ0_T0COH51M2FJOEL3tZvE7J65NUXPXuuL7Zou9dKnE3rsR0gyYw~ab3155cc0fefdab4f2c67dd1a96f5bae

Upcoming events on Viridian Therapeutics, Inc.

2024-06-17 03:00 pm Annual General Meeting
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)
2026-05-12 Q1 2026 Earnings Release (Projected)

Past events on Viridian Therapeutics, Inc.

2024-05-15 07:35 pm BofA Securities Health Care Conference
2024-05-14 08:30 am RBC Capital Markets Global Healthcare Conference
2024-05-08 08:00 am Q1 2024 Earnings Call
2024-05-08 07:00 am Q1 2024 Earnings Release
2024-03-11 02:00 pm Leerink Partners Global Biopharma Conference
2024-03-05 03:15 pm North American Neuro Ophthalmology Society Meeting
2024-03-05 12:00 pm North American Neuro Ophthalmology Society Meeting
2024-01-11 10:30 am JPMorgan Healthcare Conference
2023-12-18 08:00 am VRDN-003 IGF-1R Clinical Trial Results Call
2023-11-30 11:15 am Evercore ISI HealthCONx Conference
2023-11-15 11:00 am Jefferies London Healthcare Conference - Fireside Chat
2023-11-13 04:01 pm Q3 2023 Earnings Release
2023-11-05 06:45 pm American Academy of Ophthalmology Meeting
2023-11-04 12:45 pm American Academy of Ophthalmology Meeting
2023-11-02 American Academy Of Ophthalmology Meeting
2023-09-28 01:50 pm American Thyroid Association Meeting
2023-09-16 03:35 am European Society of Ophthalmic Plastic and Reconstructive Surgery Meeting
2023-09-15 08:20 am European Society of Ophthalmic Plastic and Reconstructive Surgery Meeting
2023-09-11 08:52 am European Thyroid Association Meeting
2023-09-11 08:40 am European Thyroid Association Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
4,46
4,32
3.38%
1,05
1,05
0.42%
2,96
3,12
-5.11%
1,77
2,13
-16.98%
0,31
0,39
-18.44%

0,37

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-65,1
-58,8
-10.86%
-134
-105
-28.12%
-187
-184
-1.58%

-195

EBIT
Million USD
Released
Forecast
Spread
-42,0
-41,5
-1.26%
-110
-26,4
-318.14%
-79,7
-68,4
-16.63%
-134
-116
-15.74%
-254
-238
-7.09%

-254

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-41,9
-41,3
-1.39%
-111
-26,9
-311.37%
-79,4
-68,2
-16.47%
-130
-114
-14.34%
-238
-224
-6.2%

-235

Net income
Million USD
Released
Forecast
Spread
-41,9
-41,3
-1.39%
-111
-26,7
-315.12%
-79,4
-68,7
-15.61%
-130
-115
-13.26%
-238
-224
-6.32%

-230

EPS
USD
Released
Forecast
Spread
-20,1
-17,1
-17.34%
-31,1
-3,18
-879.55%
-6,68
-6,42
-4.08%
-4,05
-3,57
-13.52%
-5,31
-4,94
-7.46%

-3,71

Announcement Date11/03/2026/03/2110/03/2208/03/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,22
0,25
-14.79%
0,26
0,23
10.48%
1,20
0,26
359.62%
0,11
0,46
-77.05%
0,10
0,00
-
0,07
0,20
-63.18%
0,07
0,10
-29.01%
0,07
0,15
-53.3%
0,07
0,08
-9.81%

0,09


0,09


0,12


0,12


0,12

EBITDA
Million USD
Released
Forecast
Spread
-21,2
-19,5
-8.71%
-24,6
-20,1
-22.41%
-24,8
-25,3
1.81%
-49,0
-26,2
-87.16%
-57,2
-37,0
-54.46%
-46,8
-31,5
-48.7%
-51,1
-43,5
-17.45%
-45,3
-42,0
-7.81%
-43,1
-33,6
-28.03%

-46,9


-50,9


-54,0







EBIT
Million USD
Released
Forecast
Spread
-25,9
-23,2
-11.36%
-29,6
-25,2
-17.1%
-29,8
-30,9
3.62%
-49,1
-30,8
-59.09%
-72,5
-47,1
-54.03%
-59,3
-54,1
-9.56%
-51,2
-58,2
11.99%
-71,5
-54,7
-30.77%
-55,9
-67,0
16.58%

-63,0


-65,4


-69,4


-74,5


-77,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-25,7
-23,6
-8.75%
-29,5
-24,9
-18.5%
-28,9
-29,3
1.3%
-45,8
-29,5
-55.18%
-68,2
-43,7
-56.13%
-55,1
-48,2
-14.16%
-47,7
-54,9
13.23%
-66,9
-51,3
-30.34%
-48,5
-61,1
20.61%

-59,0


-61,8


-66,0


-67,7


-68,2

Net income
Million USD
Released
Forecast
Spread
-25,7
-24,5
-4.82%
-29,5
-25,4
-16.3%
-28,9
-30,8
6.06%
-45,8
-30,3
-51.03%
-68,2
-46,9
-45.39%
-55,1
-53,3
-3.32%
-47,7
-54,2
12.11%
-66,9
-51,8
-29.17%
-48,5
-62,5
22.3%

-57,2


-61,1


-63,6


-67,7


-68,2

EPS
USD
Released
Forecast
Spread
-0,98
-1,00
2%
-1,06
-0,89
-19.55%
-0,86
-0,98
12.5%
-1,13
-0,73
-54.79%
-1,61
-0,96
-68.29%
-1,27
-1,24
-2.27%
-1,09
-1,24
11.88%
-1,35
-1,01
-34.22%
-0,79
-1,07
26.23%

-0,90


-0,96


-0,99


-0,97


-0,98

Announcement Date12/05/2215/08/2214/11/2208/03/2310/05/2308/08/2313/11/2327/02/2408/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. VRDN Stock
  4. Calendar Viridian Therapeutics, Inc.